Portfolio company
Ossium Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops bone marrow-derived cell therapies and bone allografts for healthcare providers, life science companies and researchers treating blood and immune diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orca Bio
This company develops high-precision allogeneic cell therapies to treat patients with blood cancers and autoimmune diseases by replacing diseased immune systems with donor cells.
EpiBone
This company grows personalized bone and cartilage grafts from a patient's own stem cells to treat individuals with skeletal defects.
Garuda Therapeutics
The company develops off-the-shelf blood stem cell therapies to treat patients with hematologic malignancies, sickle cell disease, and bone marrow failure disorders.
Novadip Biosciences
This company develops regenerative tissue products to treat patients with large bone defects, non-union fractures and spinal fusion requirements.
Thymmune
This biotechnology company develops scalable thymic cell therapies to restore immune function for patients with immunodeficiencies, autoimmune disorders, and transplant-related conditions.
Caribou Biosciences
This biopharmaceutical company develops genome-edited allogeneic cell therapies to treat patients with hematologic malignancies and other human diseases.
Kuros Biosciences
This company develops bone graft technologies and orthobiologics for surgeons and hospitals to facilitate bone healing and tissue regeneration.
Appia Bio
This company develops engineered allogeneic cell therapies from hematopoietic stem cells for cancer patients.
